AWM
GILD icon

Angeles Wealth Management’s Gilead Sciences GILD Stock Holding History

Angeles Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$748K Sell
5,920
-16
-0.3% -$2.11K 0.03% 196
2026
Q1 		$827K Buy
5,936
+1,744
+42% +$244K 0.05% 164
2025
Q4 		$515K Buy
4,192
+353
+9% +$42.9K 0.03% 205
2025
Q3 		$426K Sell
3,839
-115
-3% -$13.1K 0.03% 202
2025
Q2 		$438K Buy
3,954
+1,617
+69% +$172K 0.03% 197
2025
Q1 		$262K Buy
2,337
+169
+8% +$17.4K 0.02% 246
2024
Q4 		$200K Buy
+2,168
New +$195K 0.02% 294

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Angeles Wealth Management's GILD Position: Q2 2026 in Review

Angeles Wealth Management reduced its Gilead Sciences (GILD) stake by 0.27% in Q2 2026, selling an estimated $2.11K and leaving 5,920 shares worth $748K. The position accounts for 0.03% of the portfolio, ranked #196.

Angeles Wealth Management first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $827K in Q1 2026. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Angeles Wealth Management held 5,920 shares of Gilead Sciences worth $748K as of Q2 2026.
  • Angeles Wealth Management sold 16 Gilead Sciences shares in Q2 2026, an estimated $2.11K.
  • Gilead Sciences made up 0.03% of Angeles Wealth Management's portfolio in Q2 2026, its #196 holding.
  • Angeles Wealth Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Angeles Wealth Management's Gilead Sciences position peaked at $827K in Q1 2026.
  • 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Angeles Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.